We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301. Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company include ANVS-401, ANVS-405 and ANVS-301.
MALVERN, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a clinical-stage drug platform company developing novel therapies for...
The pre-market scene in the United States witnessed significant movements in various stocks, reflecting investor reactions to corporate results and future outlooks. Among the highlights...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -2.32 | -19.0476190476 | 12.18 | 12.1999 | 8.86 | 202693 | 10.06721016 | CS |
4 | -1.95 | -16.5114309907 | 11.81 | 12.575 | 8.86 | 193326 | 11.18504602 | CS |
12 | 0.67 | 7.29053318825 | 9.19 | 13.26 | 8.1001 | 221683 | 10.50278955 | CS |
26 | 2.27 | 29.907773386 | 7.59 | 22.49 | 5.42 | 253891 | 11.30605875 | CS |
52 | -6.42 | -39.4348894349 | 16.28 | 22.49 | 5.42 | 143684 | 11.41076227 | CS |
156 | -11.21 | -53.2036070242 | 21.07 | 132 | 5.42 | 254225 | 44.18560173 | CS |
260 | 0.76 | 8.35164835165 | 9.1 | 132 | 2.418 | 260554 | 33.80609391 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions